178 related articles for article (PubMed ID: 23463537)
1. Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study.
Araki T; Uchida K; Okita Y; Fujikawa H; Inoue M; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Surg Today; 2014 Feb; 44(2):291-6. PubMed ID: 23463537
[TBL] [Abstract][Full Text] [Related]
2. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
[TBL] [Abstract][Full Text] [Related]
3. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
4. Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease.
Regueiro M; El-Hachem S; Kip KE; Schraut W; Baidoo L; Watson A; Swoger J; Schwartz M; Barrie A; Pesci M; Binion D
Dig Dis Sci; 2011 Dec; 56(12):3610-5. PubMed ID: 21681507
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with infliximab and thiopurine compared to infliximab monotherapy in maintaining remission of postoperative Crohn's disease.
Sakuraba A; Okamoto S; Matsuoka K; Sato T; Naganuma M; Hisamatsu T; Iwao Y; Ogata H; Kanai T; Hibi T
Digestion; 2015; 91(3):233-8. PubMed ID: 25823572
[TBL] [Abstract][Full Text] [Related]
6. Daikenchuto, a traditional Japanese herbal medicine, for the maintenance of surgically induced remission in patients with Crohn's disease: a retrospective analysis of 258 patients.
Kanazawa A; Sako M; Takazoe M; Tadami T; Kawaguchi T; Yoshimura N; Okamoto K; Yamana T; Sahara R
Surg Today; 2014 Aug; 44(8):1506-12. PubMed ID: 24129965
[TBL] [Abstract][Full Text] [Related]
7. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease.
Sorrentino D; Paviotti A; Terrosu G; Avellini C; Geraci M; Zarifi D
Clin Gastroenterol Hepatol; 2010 Jul; 8(7):591-9.e1; quiz e78-9. PubMed ID: 20139033
[TBL] [Abstract][Full Text] [Related]
8. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
[TBL] [Abstract][Full Text] [Related]
9. [Perianal fistulas in Crohn's disease: treatment results at an interdisciplinary unit].
Iesalnieks I; Glass H; Kilger A; Ott C; Klebl F; Agha A; Schlitt HJ; Strauch U
Chirurg; 2009 Jun; 80(6):549-58. PubMed ID: 19387561
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
Louis E; Mary JY; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Porcher R; Paintaud G; Piver E; Colombel JF; Lemann M;
Gastroenterology; 2012 Jan; 142(1):63-70.e5; quiz e31. PubMed ID: 21945953
[TBL] [Abstract][Full Text] [Related]
11. Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study.
Yamamoto T; Shiraki M; Nakahigashi M; Umegae S; Matsumoto K
Int J Colorectal Dis; 2013 Mar; 28(3):335-40. PubMed ID: 23014978
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
13. Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
Chauvin A; Le Thuaut A; Belhassan M; Le Baleur Y; Mesli F; Bastuji-Garin S; Delchier JC; Amiot A
Dig Liver Dis; 2014 Aug; 46(8):695-700. PubMed ID: 24893686
[TBL] [Abstract][Full Text] [Related]
14. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
Riss S; Schuster I; Papay P; Mittlböck M; Stift A
Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
[TBL] [Abstract][Full Text] [Related]
16. Scheduled maintenance therapy with infliximab improves the prognosis of Crohn's disease: a single center prospective cohort study in Japan.
Takahashi S; Takagi S; Shiga H; Umemura K; Endo K; Kakuta Y; Takahashi S; Kinouchi Y; Shimosegawa T
Tohoku J Exp Med; 2010 Mar; 220(3):207-15. PubMed ID: 20208416
[TBL] [Abstract][Full Text] [Related]
17. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
[TBL] [Abstract][Full Text] [Related]
18. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
19. Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan.
Fukushima K; Sugita A; Futami K; Takahashi KI; Motoya S; Kimura H; Yoshikawa S; Kinouchi Y; Iijima H; Endo K; Hibi T; Watanabe M; Sasaki I; Suzuki Y;
Surg Today; 2018 Jun; 48(6):584-590. PubMed ID: 29383596
[TBL] [Abstract][Full Text] [Related]
20. Prevention of postoperative recurrence of Crohn's disease.
van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
